Export Ready — 

Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos

Bibliographic Details
Main Author: Antunes, Francisco
Publication Date: 2015
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10451/20126
Summary: One year since the begin of Ebola virus disease (EVD) outbreak in West Africa, the worst Ebola epidemic in history is ongoing. The epidemic began in Guinea during December 2013 and expanded to Sierra Leone and Liberia. The first cases of EVD, previously designated Ebola haemorrhagic fever were reported in 196F. Similar cases of haemorrhagic fever were described in 1976 from outbreaks in Sudan and Zaire. Five distinct species of Ebola virus were described (Sudan, Zaire, Tai Forest, Bundibuyo and Reston), and EVD remains a plague for the population of equatorial Africa. Almost all human cases are due to Sudan and Zaire Ebola virus. EVD is thought to be a classic zoonosis with persistence of the Ebola virus in a reservoir species, generally bats. Apes and man are regarded as end hosts. Human-to-human transmission leads to outbreaks, and EVD is spread mainly through the contact of body fluids of patients and cadavers. EVD follows an incubation period of 2-21 days and is characterized by fever, vomiting and severe diarrhea, having case-fatality rates of 50-80%. Ebola virus has a broad cell tropism with release of cytokines and other proinflamatory cellular mediators, leading to multiorgan failure. There is currently no licensed prophylaxis or treatment for EVD; therefore, treatment is merely supportive. The diagnostic of EVD is suspected in a patient with fever, and other main clinical manifestations of EVD, who have risk exposure to the Ebola virus inside or outside the geographic areas of EVD. Laboratory diagnosis is achieved primary by detection of viral particles, or particle components (PER and antigen detection ELISA) and secondary by measurement of host-specific immune response to infection (a IgM or rising IgG titre constitutes a presumptive diagnosis). Ease management is based on isolation of patients and strict barrier nursing procedures. In Africa, traditional funerals and caretaking methods contribute to the spread of the virus and potentiate outbreaks, and should be handled according to avoid the risk to Ebola virus exposure.
id RCAP_9701e5bdd22afb3a2e88f034ce9b99c6
oai_identifier_str oai:repositorio.ulisboa.pt:10451/20126
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anosEbola - from ignorance to fear or the worst acute public health crises in 50 yearsEbolaWest AfricaEpidemicOne year since the begin of Ebola virus disease (EVD) outbreak in West Africa, the worst Ebola epidemic in history is ongoing. The epidemic began in Guinea during December 2013 and expanded to Sierra Leone and Liberia. The first cases of EVD, previously designated Ebola haemorrhagic fever were reported in 196F. Similar cases of haemorrhagic fever were described in 1976 from outbreaks in Sudan and Zaire. Five distinct species of Ebola virus were described (Sudan, Zaire, Tai Forest, Bundibuyo and Reston), and EVD remains a plague for the population of equatorial Africa. Almost all human cases are due to Sudan and Zaire Ebola virus. EVD is thought to be a classic zoonosis with persistence of the Ebola virus in a reservoir species, generally bats. Apes and man are regarded as end hosts. Human-to-human transmission leads to outbreaks, and EVD is spread mainly through the contact of body fluids of patients and cadavers. EVD follows an incubation period of 2-21 days and is characterized by fever, vomiting and severe diarrhea, having case-fatality rates of 50-80%. Ebola virus has a broad cell tropism with release of cytokines and other proinflamatory cellular mediators, leading to multiorgan failure. There is currently no licensed prophylaxis or treatment for EVD; therefore, treatment is merely supportive. The diagnostic of EVD is suspected in a patient with fever, and other main clinical manifestations of EVD, who have risk exposure to the Ebola virus inside or outside the geographic areas of EVD. Laboratory diagnosis is achieved primary by detection of viral particles, or particle components (PER and antigen detection ELISA) and secondary by measurement of host-specific immune response to infection (a IgM or rising IgG titre constitutes a presumptive diagnosis). Ease management is based on isolation of patients and strict barrier nursing procedures. In Africa, traditional funerals and caretaking methods contribute to the spread of the virus and potentiate outbreaks, and should be handled according to avoid the risk to Ebola virus exposure.Um ano depois do inicio, a epidemia por vírus Ébola (VEBO), na Africa Ocidental, não esta controlada. A epidemia teve inicio em Dezembro de 2013, na Guine-Conacri e propagou-se geograficamente a Serra Leoa e a Libéria. A doença por vírus Ébola (DVE) e conhecida desde 1967, sendo as primeiras epidemias reconhecidas, a partir de 1976, no Sudão e no Zaire. São conhecidas cinco estirpes de VEBO (Sudan, Zaire, Tai Forest, Bundibuyo e Reston), sendo a Sudan e a Zaire as principais responsáveis pelos surtos epidémicos na Africa Equatorial. DVE e uma zoonose clássica, com potenciais reservatórios em morcegos, sendo os macacos e o homem hospedeiros definitivos. No homem, cuja transmissão se processa através do contacto com doentes ou com cadáveres, apos 2-21 dias de período de incubação, o quadro clinico caracteriza-se, principalmente, por febre, vómitos e diarreia grave, rondando a mortalidade 50-80%. VEBO tem tropismo celular alargado, que, pela libertação de citocinas e outros medidores celulares pro-inflamatórios, pode levar a falência multiorgânica. A sobrevida parece depender dos cuidados de saúde prestados, incluindo os de suporte de vida, dado não se dispor de terapêutica antivírica, comprovadamente eficaz. O diagnostico deve ser suspeitado num doente com febre, que tenha estado em região endémica, devendo ser confirmado por uma técnica de PCR ou pela pesquisa de anticorpos por um método ELISA. Não existe vacina disponível, pelo que a prevenção passa pelo isolamento dos doentes, pela utilização de material protector individual e, em Africa, pela modificação dos cuidados prestados aos doentes e das praticas tradicionais dos funerais.Sociedade Portuguesa de Doenças Infecciosas e Microbiologia Clínica (SPDIMC)Repositório da Universidade de LisboaAntunes, Francisco2015-09-23T14:10:21Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/20126porRevista Portuguesa de Doenças Infecciosas. jan-abr 2015, Vol. 11 Issue 1, pp. 7-10.0870-1571http://spdimc.org/revista/metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-17T13:20:37Zoai:repositorio.ulisboa.pt:10451/20126Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T02:41:15.055177Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
Ebola - from ignorance to fear or the worst acute public health crises in 50 years
title Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
spellingShingle Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
Antunes, Francisco
Ebola
West Africa
Epidemic
title_short Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
title_full Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
title_fullStr Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
title_full_unstemmed Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
title_sort Ébola - da ignorância ao medo ou a maior crise aguda de saúde pública nos últimos 50 anos
author Antunes, Francisco
author_facet Antunes, Francisco
author_role author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Antunes, Francisco
dc.subject.por.fl_str_mv Ebola
West Africa
Epidemic
topic Ebola
West Africa
Epidemic
description One year since the begin of Ebola virus disease (EVD) outbreak in West Africa, the worst Ebola epidemic in history is ongoing. The epidemic began in Guinea during December 2013 and expanded to Sierra Leone and Liberia. The first cases of EVD, previously designated Ebola haemorrhagic fever were reported in 196F. Similar cases of haemorrhagic fever were described in 1976 from outbreaks in Sudan and Zaire. Five distinct species of Ebola virus were described (Sudan, Zaire, Tai Forest, Bundibuyo and Reston), and EVD remains a plague for the population of equatorial Africa. Almost all human cases are due to Sudan and Zaire Ebola virus. EVD is thought to be a classic zoonosis with persistence of the Ebola virus in a reservoir species, generally bats. Apes and man are regarded as end hosts. Human-to-human transmission leads to outbreaks, and EVD is spread mainly through the contact of body fluids of patients and cadavers. EVD follows an incubation period of 2-21 days and is characterized by fever, vomiting and severe diarrhea, having case-fatality rates of 50-80%. Ebola virus has a broad cell tropism with release of cytokines and other proinflamatory cellular mediators, leading to multiorgan failure. There is currently no licensed prophylaxis or treatment for EVD; therefore, treatment is merely supportive. The diagnostic of EVD is suspected in a patient with fever, and other main clinical manifestations of EVD, who have risk exposure to the Ebola virus inside or outside the geographic areas of EVD. Laboratory diagnosis is achieved primary by detection of viral particles, or particle components (PER and antigen detection ELISA) and secondary by measurement of host-specific immune response to infection (a IgM or rising IgG titre constitutes a presumptive diagnosis). Ease management is based on isolation of patients and strict barrier nursing procedures. In Africa, traditional funerals and caretaking methods contribute to the spread of the virus and potentiate outbreaks, and should be handled according to avoid the risk to Ebola virus exposure.
publishDate 2015
dc.date.none.fl_str_mv 2015-09-23T14:10:21Z
2015
2015-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/20126
url http://hdl.handle.net/10451/20126
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Revista Portuguesa de Doenças Infecciosas. jan-abr 2015, Vol. 11 Issue 1, pp. 7-10.
0870-1571
http://spdimc.org/revista/
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Doenças Infecciosas e Microbiologia Clínica (SPDIMC)
publisher.none.fl_str_mv Sociedade Portuguesa de Doenças Infecciosas e Microbiologia Clínica (SPDIMC)
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833601455031844864